Navigation Links
Sangamo BioSciences to Present at the Cowen and Company 28th Annual Health Care Conference
Date:3/11/2008

RICHMOND, Calif., March 11 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic development programs and an overview of the company's business strategy at 9:30 a.m. (ET) on Tuesday, March 18, 2008 at the Cowen and Company 28th Annual Health Care Conference in Boston.

The presentation will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Investor Relations section http://investor.sangamo.com/index.cfm under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in Phase 2 clinical trials for evaluation of safety and clinical effect in patients with diabetic neuropathy. Phase 1 clinical trials are ongoing to evaluate a ZFP Therapeutic for peripheral artery disease. Other therapeutic development programs are focused on stem cell mobilization, ALS, cancer, HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TF(TM)) that can control gene expression and, consequently, cell function. Sangamo is also develop
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sangamo BioSciences Presents Data Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
2. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
3. Sangamo BioSciences to Present at the 2007 BIO InvestorForum
4. Sangamo BioSciences Announces Third Quarter 2007 Conference Call and Webcast
5. Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting
6. Sangamo BioSciences to Present at the Piper Jaffray Health Care Conference
7. Sangamo BioSciences to Present at the BMO Capital Markets Health Care Conference
8. Sangamo BioSciences to Webcast Presentations at Investor and Analyst Briefing
9. Sangamo BioSciences Announces Fourth Quarter and Year-End 2007 Conference Call and Webcast
10. Sangamo BioSciences to Present at the BIO CEO & Investor Conference
11. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2008)..., China, July 2 /Xinhua-- WuXi Pharma...nology and medical device research,and development...the United,States, today announced that it has app...urces., (Logo: http://www.newscom.com/cgi-bin/pr...PharmaTech, Mr. Zhu worked as Head of Asia Human,R...
(Date:7/1/2008)...o (June 30, 2008) Researchers at The University o...or Emerging Infectious Diseases and The University...HSCSA) have identified a cell type believed to pla...ss against Francisella tularensis, a respiratory... of tularemia. The findings will be released this ...
(Date:7/1/2008)... Calif., July 1 /- Microfluidic Syste...arded the Phase 3X agreement for,the production of...ctor,(M-BAND). This award is the fourth in a serie...gy Directorate since 2003. The continued funding,t...ction of automated,systems for extended field tria...
(Date:7/1/2008)...ILL, N.C., July 1 /- To effectively m...surveys garnered the highest,rating of 3.93 out of...es,in a member-driven research study conducted by ..., However, only 35 percent of companies use this ...lth care segment not using follow-up CSR phone,sur...
Breaking Biology Technology:WuXi PharmaTech (NYSE: WX) Appoints Mr. Bob Zhu as VP of HR 2UTSA/UTHSCSA publish results on bio-threat agent 2Microfluidic Systems Receives Continued Funding From the Department of Homeland Security (DHS) Toward the Commercial Production of Autonomous Airborne Pathogen Detection Systems 2Microfluidic Systems Receives Continued Funding From the Department of Homeland Security (DHS) Toward the Commercial Production of Autonomous Airborne Pathogen Detection Systems 3Follow-up Phone Surveys: Effective Customer Service Assessment Tool for Improving Satisfaction 2
...rms that use slogans and catchy buzz-phrases to ca...ve ear of executive management. Economic developme... those slogans. , ,When a slogan or phrase rings ...des faster than the T-shirts and hats it is printe...ecause future economic viability is going to hinge...
...n Milwaukee and perhaps throughout Wisconsin will ... digital inclusiveness as Milwaukee moves toward c... ,The City of Milwaukee , having finalized a cont... citywide wireless Internet network, will pursue f...ide, including the provision of low-cost or refurb...
...nd in city and state government is joining a new g...o attract federal grant money for start-up bioscie...Wisconsin lobbying firm Hamilton Consulting Group.... Sanders will focus on Hamilton,s new government ... in collaboration with the national economic devel...
...oping diagnostics to test for kidney disease is pr...ts to secure federal clearance for its first clini...a total of $3.2 million since its inception in 199... round for additional product research and develop...sed NEW Capital Fund , and also included Wisconsi...
Other Biology Technology:Locations must have connectivity to be viable 2Locations must have connectivity to be viable 3Locations must have connectivity to be viable 4Businesses could bridge digital divide in Milwaukee with used computers 2Businesses could bridge digital divide in Milwaukee with used computers 3Renovar captures $1.2M for product development 2
(Date:7/3/2008)...GE, Mass., July 3, 2008 -- Sirtris, a GlaxoSmithKl...small molecule drugs to treat diseases of aging su...h team that reported in today,s online edition of ...to the end-of-life with resveratrol showed an over...alth, a reduction in cataracts and cardiovascular ...
(Date:7/3/2008)...bservation satellites have provided vital informat...icularly long crisis response window following the...n 2 and 3 May 2008. , Immediately after the disa...tarian Affairs (OCHA) asked the International Char... ,the Charter, for support by providing immediate...
(Date:7/3/2008)... TexasA dynamic way to alter the shape and size of...t of proteins has been developed by biological che...ryan Kaehr at The University of Texas at Austin. ,...d three-dimensional microstructures, known as hydr...d the hydrogels by altering the chemistry of the e...
(Date:7/3/2008)... Moines, Iowa July 3, 2008 Endangered wild orang...harply in Sumatra and Borneo than previously estim...th by Great Ape Trust of Iowa scientist Dr. Serge ...Oryx The International Journal of Conservation . ...f orangutans, found only on the islands of Sumatra...
Breaking Biology News(10 mins):Long-term study of middle-aged mice shows 2Long-term study of middle-aged mice shows 3Extended cyclone relief efforts aided from space 2Extended cyclone relief efforts aided from space 3'Smart' materials get smarter with ability to better control shape and size 2'Smart' materials get smarter with ability to better control shape and size 3Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 2Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 3Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 4Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 5Scientists uncover the potential to control adult stem cells 2841 1Scientists uncover the potential to control adult stem cells 2841 2Consumerism Driving Healthcare Change 16463 1Consumerism Driving Healthcare Change 16463 2Loma Linda University Partners With Larta Institute for Technology Marketing Program 4519 1Loma Linda University Partners With Larta Institute for Technology Marketing Program 4519 2Postmenopausal Womens Sexual Dissatisfaction Not Linked to Heart Troubles 16462 1Postmenopausal Womens Sexual Dissatisfaction Not Linked to Heart Troubles 16462 2
...dresses western medicine & society,s embrace o...ns Medical Dean Edward Miller, and Georgetown Univ... With Western medicine,s increasing interest in me...g, the Mind & Life Institute, in partnership w...the Johns Hopkins University School of Medicine wi...
...ound in the Welsh national flower, which could off...eing supported for large scale manufacture by Card...(MEC). , Alzheimer,s disease is the most common fo... of dementia. Dementia affects one person in 20 ov...ge of 80. , Certain species of daffodil, which th...
... Florida researchers say they are a step closer to...ncers before symptoms become apparent. , The findi...tional Academy of Sciences, involve introducing mo...ures and observing whether they unleash a fluoresc..., The technique could enable doctors to search wit...
...t Stanford University have created a larger-than-n...ently as natural DNA. The findings, reported in th... National Academy of Sciences (PNAS), may reveal n...es that occur during DNA replication-arise. The di... professor of chemistry at Stanford and co-author ...
Other Biology News:Dalai Lama, top scientists to discuss science & clinical applications of meditation 2Dalai Lama, top scientists to discuss science & clinical applications of meditation 3Scientists closer to new cancer detection method 2Scientists closer to new cancer detection method 3DNA size a crucial factor in genetic mutations, study finds 2DNA size a crucial factor in genetic mutations, study finds 3
...2 is an essential component of the COP9 signalosom...lular and developmental processes. The CSN complex...conjugation pathway by mediating the deneddylation...lexes. The complex is also involved in phosphoryla...
6B9
Taq DNA Polymerase (T. aquaticus), 250 units. For PCR and other procedures requiring DNA polymerase activity at elevated temperatures. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzyme
Recombinant DNA polymerase from Thermus aquaticus expressed in E. coli; 5 units/L; 1 tube of 1, 000 units enzyme/tube w/Buffer II and MgCl2
Biology Products: